Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4680045 Target Snapshot

SLC34A2-ROS1 · CHIMERIC PROTEIN · Homo sapiens

7Compounds
18Assays
2Approved Drugs
8.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P08922. Use UniProt P08922 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P08922 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats SLC34A2-ROS1 as ChEMBL target CHEMBL4680045, mapped to UniProt P08922. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
SLC34A2-ROS1
CHIMERIC PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL4680045
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P08922
Proto-oncogene tyrosine-protein kinase ROS
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether SLC34A2-ROS1 is the right protein anchor across sources, using UniProt P08922 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelProto-oncogene tyrosine-protein kinase ROS
UniProt AccessionP08922
Component TypeProtein
Sequence Length2347 aa

Proto-oncogene tyrosine-protein kinase ROS

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as SLC34A2-ROS1, mapped to UniProt P08922. ChEMBL maps the protein component as Proto-oncogene tyrosine-protein kinase ROS. Sequence length is 2347 aa.

Mapped IDP08922
Review nameSLC34A2-ROS1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase II
Assay Mix

Activity Type Distribution

IC508.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3286830 9.72 IC50 0.19 Approved
CHEMBL5712062 9.72 IC50 0.19 Preclinical
CHEMBL601719 7.29 IC50 51.0 Approved
CHEMBL1230609 7.0 IC50 99.0 Clinical
Distribution

pChEMBL Value Distribution

0
5.0
0
5.5
0
6.0
0
6.5
3
7.0
0
7.5
0
8.0
0
8.5
0
9.0
2
9.5
pChEMBL
Approved Drugs

Approved Drugs

LORLATINIB
CHEMBL3286830
Approved 2018
CRIZOTINIB
CHEMBL601719
Approved 2011
Assay Landscape

Assay Landscape

18
Total Assays
4
Tested Compounds
1
Assay Types
Binding — 18 assays, 4 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 18 4 8.2

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine